Paradigm Biopharmaceuticals Ltd is a late-stage clinical development company engaged in the research and development of therapeutic products for human use in Australia... Show more
Industry Biotechnology
A.I.dvisor indicates that over the last year, PBIGF has been loosely correlated with ABEO. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PBIGF jumps, then ABEO could also see price increases.
| Ticker / NAME | Correlation To PBIGF | 1D Price Change % | ||
|---|---|---|---|---|
| PBIGF | 100% | N/A | ||
| ABEO - PBIGF | 34% Loosely correlated | -0.21% | ||
| STTK - PBIGF | 21% Poorly correlated | N/A | ||
| ARWR - PBIGF | 21% Poorly correlated | -0.97% | ||
| OXBDF - PBIGF | 7% Poorly correlated | +30.63% | ||
| PTCHF - PBIGF | 6% Poorly correlated | -4.85% | ||
More | ||||